​

​

Accepted Abstracts will be published in the American Heart Journal.

Editor-in-Chief: Daniel Mark, MD, MPH

​​

​

​

Late Breaking Abstract Submission Deadline: Starting May 6th - 22nd, 2025
Accepted Abstracts will be published in the American Heart Journal, Editor-in-Chief: Daniel Mark, MD, MPH
Accepted Abstracts will have a poster presentation at the meeting.
Top Abstracts will be selected for oral presentation at the meeting.
Top 4 Abstracts will receive awards and cash prizes.

  
Abstract Submission Topics
Abstracts should address state-of-the-art clinical research aspects of diabetes and the heart. (As an example, obesity by itself will NOT qualify, but obesity as it relates to diabetes and/or cardiovascular disease will qualify). 

 

​Encore abstracts are accepted under special circumstances. Make sure to identify your abstract as an encore if it was published or presented in a different conference when you submit your entry. Please note that Encore abstracts will not be published and will not be eligible for oral abstract presentations or awards.  In addition, upon acceptance of your encore abstract, at least one of the authors or a representative should be registered for the conference and is present on-site to present their posters during the meeting.
​
Topics Include: diabetes, hypoglycemia, prediabetes, and/or cardiometabolic syndrome, retinopathy, obesity, neuropathy, dyslipidemia, triglycerides, cholesterol, hypertension, congestive heart failure (CHF), atherosclerosis, cardiovascular disease, arrhythmia, kidney/renal disease, cardiorenal syndrome, thrombosis, coagulation abnormalities, therapeutics, clinical trials, cardiovascular outcome trials, epidemiology, fatty liver, inflammation, guidelines on practice, technology, peripheral vascular disease, and related conditions. Although the posters are not designed for basic science, abstracts that consider unknown MOA (mode of action) of medications or pathophysiology of related medical conditions may be accepted.

 

Special Notice:

All abstracts submitted are being checked for plagiarism. Of note, the software is able to identify plagiarism based on all international journals. Abstracts that will be identified as such, will not be published and the authors will be barred from future submission. 

 
​
Abstract Poster Presentations
Abstracts may be submitted for poster presentation. If selected for poster presentation, the author(s) or presenter(s) are required to register for the Congress and to be present during the poster sessions. The presenter in attendance must be one of the authors listed in the abstract. 

 

Abstract Oral Presentations
Four of the highest-ranking abstracts will be selected for the Abstract Oral Presentation Session. In some cases, the committee may consider Late-Breaking Abstracts for oral presentation. The authors of the winning abstracts will present their research findings in a 10-minute presentation, followed by 5 minutes of Q&A. If selected, an author is required to register for the meeting and to be prepared with a PowerPoint presentation. Oral presenters who have an interest or involvement in selling a technology, program, product, and/or service to healthcare professionals must submit an official disclosure document to be considered for and to present their work at the abstract oral session.   ​ 

 
Top Abstract Awards
Awards will be given to the highest-ranking abstracts. The award levels are: Gold, Silver, Bronze, and honorable mention.    
**Please note: If an author wishes to make changes or withdraw their abstract, they must contact our staff no later than

May 20, 2024. HiD cannot guarantee that any change or withdrawal requests submitted after this date will be accommodated. Any requests should be submitted via e-mail to info@tmioa.com.

In addition:

• Abstracts and scientific materials presented at the 8th Annual Heart in Diabetes (2024) must not have been published or presented prior to June 07, 2024.

• Encore abstracts are accepted under special circumstances, provided that upon selection at least one of the authors should be registered for the conference and is present on-site to present their posters during the meeting. Please note that Encore abstracts will not be published under the American Heart Journal and will not be eligible for oral abstract presentations or awards.

• All abstracts must be submitted electronically in Microsoft Word format and should be no more than 250 words (Titles, author(s) names, and affiliations are not included in the word count).

• Graphs or figures submitted must be in TIFF or JPG format.

• All materials must arrive on or before the abstract deadline noted above.

• Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.

• Authorship on multiple abstracts is permitted.

• All submitted content will be graded by the 2024 Heart in Diabetes Scientific Abstract Committee.

• Abstracts will be published in an issue of the American Heart Journal. Click on the images to see a sample of the recently published works. 

​​

The Abstract Poster Reception at the Exhibit Hall starts on Friday, June 7, from 6:15 pm to 7:15 pm. Early Poster Set-up will be available on Thursday, June 6, 2024, from 11:00 am to 6:00 pm. Please have your posters placed on your designated board before the day of the conference, as the Exhibit Hall opens on Friday, June 7, 2024, at 7:00 am.

 

ePosters are due May 31, 2025.
ePosters are PDF copies that will be displayed on our virtual platform.

The Abstract Oral Presentation is on Saturday, June 7, 2025, starting at 8:00 pm to 9:00 pm.
The Oral Abstract Winner Award Presentation is on Sunday, June 8, 2025, at 8:00 am.
Important Notice:  "Make sure you include in all abstracts involving human or animal  studies state approval by ethics committees as well as authors’ affiliation in detail and country of origin."

​

Important Notice: "Make sure you include in all abstracts involving human or animal studies state approval by ethics committees as well as authors’ affiliation in detail and country of origin."

​

​

​

​

​